Revelation Biosciences, Inc. (NASDAQ: REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is ...

“We look forward to demonstrating the same protective effect in cells collected from CKD patients, which will be an excellent surrogate of future efficacy of Gemini in our target indications.

announced Gemini priming attenuates the inflammatory response in human peripheral blood mononuclear cells (PBMCs) exposed to clinically relevant promoter molecules of inflammation. Revelation ...